Searched for
INSULIN DISCOVERY
In 1921, a Canadian pharmacologist co-discovered a life saving medicine. Two years later, the inventors sold the patent for just $1Canadian pharmacologist Sir Frederick Banting along with other inventors created the life saving medicine, insulin. The decision of selling...
The rice on your plate may affect blood sugar differently than you think — scientists find black and green varieties contain unusual fats and slower-digesting starchResearchers discovered diverse lipid molecules within Japanese rice grains. Black and green rice varieties showed unique fat profiles and s...
Type 2 diabetes patients on metformin, take note: After 60 years, scientists find this drug has hidden effects on the brainDiabetes: Recent studies reveal that metformin may influence blood sugar management via the brain. This medication stimulates a distinct br...
Type 2 diabetes medicine widely used since 1922 may affect blood sugar patient's brain, claims recent studyMetformin may have been part of diabetes medicine for generations, but scientists are still uncovering new chapters in its story. The possi...
Shantha Biologics to make injectable drug cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulinIn a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the panc...
Cure for Type 1 diabetes? Cancer research accidentally stumbles upon 90 per cent effective ‘sugar-coating’ methodMayo Clinic scientists have made a breakthrough in type 1 diabetes treatment. They discovered a 'sugar coating' method. This protects insul...
Wockhardt exits US generics biz to focus on drug discoveryWockhardt is set to exit its loss-making US generics business to prioritize innovation, focusing on new antibiotic drug discovery and its b...
How a 14-year-old’s medical treatment in 1922 revolutionized diabetes care and led to a historic four-way Nobel Prize splitThe invention of insulin in 1922 marked a turning point in medical history. Sparked by Frederick Banting’s idea and tested on diabetic pati...
No more insulin injection for diabetics? New capsule gives hopeAustralian scientists have designed a new type of oral capsule that could one day mean pain-free delivery of insulin and other protein drug...
Being overweight ups risk of diabetes. New study explains why and tips to delay the onsetThe findings have been published in the journal Cell Metabolism.
Biocon Biologics to partner with International Diabetes FederationGlobal Head of Market Access & Policy, Biocon Biologics, Alexander Zach, said:"Given our extensive experience in providing affordable insul...
Forget painful needle pricks, our body may cure diabetes itself in futureResearchers have identified cells that can take over functions of damaged or missing insulin-producing cells.
- Sea-snail venom holds key to diabetes medication
Melbourne, Sep 13 (IANS) The venom of a carnivorous sea snail could hold the key for artificial, fast-acting insulin for diabetes patients,...
Potential biomarker for pre-diabetes discoveredResearchers have identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type 2 diabetes.
Indian scientists develop insulin pill for diabeticsIndian scientists have developed a long-sought insulin pill that could spare millions of diabetics around the world the pain of daily jabs.
- Biocon close to oral insulin deal with Bristol-Myers Squibb
Four months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bri...
- We plan to expand clinical research in India: Novo Nordisk President and CEO
In an interview with ET, Novo Nordisk's president and CEO Lars Rebien Sorensen talks of the growing transfer of accounting and patenting wo...
- Clinical trials for oral insulin to enter phase two: Biocon
After the success of its recomibant human insulin "Insugen", Biocon said clinical trials for the oral insulin would soon enter phase two.
- Wockhardt in talks to out-license research molecules
Wockhardt is likely to out-license some of its research molecules to global pharma companies.